Clinical Genitourinary Cancer
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.4 | Q2 | 58.2% | 1.050 | Q1 | 85.2% |
| 2024 | 2.7 | Q2 | 71.6% | 1.130 | Q1 | 87.1% |
| 2023 | 2.3 | Q2 | 60.3% | 1.056 | Q1 | 86.9% |
| 2022 | 3.2 | Q2 | 76.8% | 1.031 | Q1 | 86.9% |
| 2021 | 3.1 | Q2 | 69.7% | 0.850 | Q1 | 82.8% |
| 2020 | — | — | 1.229 | Q1 | 89.4% | |
| 2019 | — | — | 0.970 | Q1 | 85.0% | |
| 2018 | — | — | 0.981 | Q1 | 83.7% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1938-0682
ISSN
1558-7673
country
UScoverage
2005-2026